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Abst rac t
Compression therapy (CT) is an established treatment method in chronic venous disease. Despite years of clinical 
experience, choosing the optimum compression therapy, including grade and pressure distribution, which determine 
the efficacy of treatment poses a challenge. The paper discusses CT physical assumptions (stiffness, elasticity, static 
and dynamic stiffness indices), clinical effects and contraindications to CT. 
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Introduction
Chronic venous disease (CVD) is associated with 
significant morbidity and burden to the patients, soci-
ety and healthcare system [1]. In the US, the venous leg 
ulceration is associated with the annual treatment cost 
of over USD 3 billion [2, 3]. In Western Europe, the CVD 
treatment cost amounts to 1–2% of annual health budget 
in individual countries [4]. The magnitude of CVD-associ-
ated problems and costs is ever increasing. In the United 
States, where the healthcare system aims at reducing the 
cost of medical procedures, the expenses for the treat-
ment of CVD-associated complications cannot be cut 
down and due to the absence of uniform standards for 
CVD treatment, treatment costs are now transferred on 
the affected patients [5]. Therefore, choosing the opti-
mum treatment and developing management standards 
appear crucial. Compression therapy (CT) is a basic treat-
ment for venous and lymphatic disorders. 
Physical assumptions of compression therapy
Compression therapy works by exerting external 
pressure on lower extremities and preventing the grav-
ity which impairs venous and lymphatic outflow. Com-
pression therapy aims at preventing intraluminal venous 
pressure increase so as to reduce vascular wall tension 
[6, 7]. The CT works in accordance with Laplace’ law and 
Pascal’ law. Laplace’ law describes the relationships be-
tween forces acting in spherical and cylindrical vessels. 
According to the Laplace’ law, the tension of the vascular 
wall increases along with the pressure across the ves-
sel wall [8]. The Laplace’ law enables computing surface 
pressure exerted by a textile placed onto a surface of 
a cylindrical vessel [7]. The compression force exerted by 
a compression textile is directly proportional to its ten-
sion, and inversely proportional to the radius of the leg. 
It is expressed by the following equation: P = T/R, where 
P – pressure under the textile, T – tension of compression 
textile, R – leg radius.
In multilayer compression systems, the P value is cal-
culated using the modified Laplace equation, which uses 
the tension of each layer, number of layers, leg circumfer-
ence and bandage width. It is expressed by the following 
equation: P = (T × number of layers × 4620)/(leg circum-
ference (cm) × bandage width (cm)) [9].
The Pascal’ law, on the other hand, describes pres-
sure distribution in an incompressible fluid-filled con-
tainer surrounded by stiff material. It assumes that the 
pressure will be equally distributed in the covered com-
partment [10]. This occurs, for example, within the soft 
tissue of the bandaged leg if stiff, non-tensile compres-
sion systems are used, when muscles contract under 
a textile layer [9]. 
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Properties of textiles are characterized using specific 
parameters which enable their optimum selection for 
CVD severity. They include stiffness, elasticity, static and 
dynamic stiffness indices as well as surface tension gen-
erated when applying the textile [11]. 
Stiffness
Stiffness is the ability of a textile to resist deforma-
tion under stress. It describes the relationship between 
the tensile force and textile stretch. Stiffness is the key 
property to differentiate between elastic and inelastic 
materials [10]. According to the European Committee 
for Standardisation (Centre Europeen de Normalisation, 
CEN), stiffness is defined as the pressure increase pro-
duced by muscle contraction per centimetre of increase 
in leg circumference, expressed in hectopascals per centi-
metre and/or millimetres of mercury per centimetre [10–
12]. Measurements of stiffness are performed in textile 
laboratories using extensometers on a mannequin leg 
designed by Hirai et al. The pressure increase produced 
by medical compression hosiery (MCH) per centimetre of 
increase in leg circumference corresponds to the CEN’s 
definition of stiffness [12]. Stiffness classification accord-
ing to CEN identifies three stiffness classes (Table 1) [10]. 
In vivo measurements are performed at the B1 point, 
10–15 cm above the medial malleolus, at the segment 
where at the medial side of the leg, the muscular part of 
the gastrocnemius muscle turns into the tendinous part. 
The B1 point is the area which shows the maximal exten-
sion during movement, ranging from several millimetres 
to 1.5 cm [12, 13]. 
Elasticity
Elasticity is the textile’s ability to return to its original 
size after the pressure has been reduced [14]. Most ma-
terials used for compression therapy are elastic to some 
extent. However, there are also inelastic ones, such as 
zinc paste bandages or rigid Velcro straps [7, 15]. Elastic-
ity depends on the presence of basal fibres, such as latex 
or elastane (Lycra), and functional properties of the ma-
terial [16]. Maximal stretch is the deciding parameter for 
differentiating elastic and inelastic compression materi-
als. Thus, the materials of maximal stretch above 100% 
are considered elastic and those of maximal stretch of 
10–100% are considered inelastic [10, 17]. A more detailed 
classification, though, differentiates between four cate-
gories of materials (Table 2) [15]. This simple concept may 
still be valid for the differentiation of a single bandage 
product. However, it does not apply to multicomponent 
or elastic-inelastic complex compression systems [10]. 
The elastic properties of the material determine its ef-
fect on the pressure at standing and in the supine resting 
position as well as working pressure generated during 
walk, when muscle contraction and dynamic changes in 
leg circumference lead to an increase in pressure under 
the compression material [2, 11, 12]. The pressure gen-
erated underneath the elastic material during walking 
can be compared with the standing pressure, which is 
only slightly higher than the resting pressure [10, 17, 18]. 
Inelastic materials, due to their high stiffness and low 
elasticity, generate high systolic pressure peaks during 
walking and exercise and low resting pressure [17, 18]. 
Owing to such properties, inelastic compression materi-
als are able to improve the venous pump more effectively 
than elastic materials [18, 19].
Interface pressure 
Interface pressure (IP) is a pressure at the interface of 
two surfaces. In CT, it is the pressure between the com-
pression device and skin [18]. It is the pressure exerted by 
compression material on the leg [20]. Interface pressure 
is a direct effect of elasticity of the compression material 
and muscle activity [10, 12, 20]. Thus, IP describes a dose 
of compression therapy which correlates with its clinical 
effectiveness. The relationship between them is not al-
ways linear [12]. Owing to standardized IP measurement, 
it is possible to compare and develop new compression 
systems as well as to select the optimum compression 
option for individual clinical situations. IP is measured 
under the compression layer, preferably at the B1 point 
[18, 21, 22]. Commercially available measurement de-
vices include Picopress (Microlabitalia, Padua, Italy) and 
Kikuhime (Meditrade, Soro, Denmark) as well as piezore-
sistive pressure sensors. Both types offer a comparable 
measurement accuracy [22]. There are also newer devic-
es which enable real-time IP measurement. This principle 
has been used to develop a functional prototype smart 
bandage (SB) into which silver strain gauge transducers 
are knitted. A connection point and digital electronics to 
detect the transducer output are located at a bandage 
extremity. These wirelessly connect to a user interface 
(a Bluetooth user interface, for example a smartphone 
or tablet) with an app that reports the values of applied 
pressure in real time [6]. Table 1. Stiffness classification according to the European 
Centre for Standardization (CEN) [10]
Stiffness Pressure [mm Hg]
Low 0–2
Medium 2–4
High 4–6
Table 2. Categories of compression materials [15]
Extensibility
Inelastic Short stretch Intermediate stretch Long stretch
0 < 70% 70–140% > 140%
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Choosing appropriate IP along with its maintenance 
are the key to effective compression treatment. The level 
of compression should be adjusted to symptom sever-
ity and limited with the value of the minimum effective 
compression [23]. Adequate compression ensures the op-
timum clinical benefit, what is presented in Table 3. For 
the external compression to affect venous haemodynam-
ic in the upright position, the interface pressure should 
exceed intravenous pressure ranging between 60 and 
100 mm Hg [10, 24, 25]. However, long-term continuous 
external compression above 60–70 mm Hg may cause 
tissue damage. As a consensus, it was therefore accepted 
that optimum compression therapy depends on the body 
position and mimics physiological pressure distribution, 
with the lowest possible resting pressure and short, high 
pressure spikes generated during walking [2, 10]. 
Different compression therapy forms deliver target 
interface pressure in different ways. For example, the 
interface pressure and compression profiles of compres-
sion hosiery are provided by the manufacturer. With 
bandage, it is more difficult to achieve and maintain 
the target interface pressure. Bandaging is subjective 
and depends on the skills of the person as well as the 
force they use for bandaging. To a lesser extent, it also 
depends on elastic properties of the bandage and the 
number of layers. Furthermore, as the leg circumference 
decreases, it is more difficult to maintain constant in-
terface pressure, which is why it (and, as a result, the 
effective compression dose, as well) cannot be precisely 
determined in most cases [14, 26–28]. On the other hand, 
the intermittent pneumatic compression (IPC) devices of-
fer predefined compression and interface pressure. The 
settings are either fixed or individually selected depend-
ing on venous filling time. The compression force may be 
applied either uniformly to the calf using a single cham-
ber device or through a series of chambers inflated in 
a sequential manner from the ankle to thigh [29, 30]. It is 
also possible to control pressure values independently in 
individual chambers [31]. The adjustable Velcro compres-
sion devices (AVCDs) ensure maintenance of optimum 
interface pressure by using a special in-built/built-in 
compression measurement system [32, 33]. Another de-
vice which ensures constant resting interface pressure all 
day long is the Lundatex compression system (PressCise, 
Herrljunga, Sweden) which has been used in research. 
It consists of two components, the Lundatex® medical 
bandage, which provides a safe and well-defined resting 
pressure owing to a cross-line indicator system, and two 
velcro products called PressPatch™ and FixPatch™. Add-
ing stiff velcro products not only turns an elastic bandage 
into an inelastic compression device, but also enables 
hassle-free maintenance of target interface pressure by 
readjusting the FixPatch, without the need to re-bandage 
[19, 26]. 
Static Stiffness Index 
The Static Stiffness Index (SSI) has been proposed 
as a parameter for assessing the elasticity (stiffness) of 
a compression device in vivo. The SSI is the difference be-
tween standing pressure and resting pressure. Both mea-
surements are taken at the B1 point [10, 12]. For the resting 
pressure measurement, the measuring site is on the leg 
at the heart level with relaxed knee and ankle joint. For 
the standing pressure, the measurement is taken 2–3 min 
after standing up and after the leg veins are filled. SSI 
over 10 denotes a high stiffness and inelasticity of the 
compression material/system. The Static Stiffness Index 
below 10 denotes a low stiffness and elasticity of the 
compression material/system [10, 20]. The SSI of com-
pression hosiery is usually low, below 5 [10]. It depends 
on the properties of yarn, which determine the thickness 
and stiffness of the compression product as well as the 
type of knit, usually higher in thicker and stiffer, flat knit 
products [16]. Flat knit compression hosiery can offer SSI 
above 10. Increase in SSI can be explained by the elastic 
properties of the compression material, the number of 
layers and friction between the layers. Four-layer ban-
dages showed an SSI value of 15 as regards inelastic 
bandages, and SSI values measured under a zinc-paste 
bandage can reach even 40 mm Hg. The Static Stiffness 
Index depends not only on the type of material but also 
on anatomy and muscle strength. It will, therefore, be 
higher, in individuals with well-developed musculature 
as compared to slim, asthenic or obese ones as well as 
those with lymphoedema [10]. 
Table 3. Interface pressure (IP) value and clinical effect of compression therapy [2, 7, 19, 24, 25]
Clinical effect IP range [mm Hg]
1–10 10–20 20–30 30–40 > 40
Oedema reduction Yes Yes Yes Yes Yes
Increased venous flow
Reduced venous diameter in a supine position
Yes Yes Yes Yes
Improved microcirculation
Improved venous pump function
Improved venous emptying
Yes Yes Yes
Reduced vein diameter in a standing position Yes Yes
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Dynamic Stiffness Index (DSI)
The Dynamic Stiffness Index (DSI), estimated during 
walking, describes the coexistence of dynamic changes 
in leg circumference and IP. The importance of DSI can 
be explained by hysteresis, that is, the effect of the pre-
ceding condition of the system on its current condition. 
When applied to compression therapy, it means delayed 
response of material fibres to an external factor, such as 
muscle stretch-relaxation. During a normal walking speed, 
the elastic elongation of compression hosiery is unable to 
keep up with the circumferential changes of the leg. As 
a result, the IP rises when leg muscles contract and drops 
when they relax. This phenomenon is known as the mas-
saging effect with pressure peaks during walking, which 
determine the clinical efficacy of a compression product 
[12]. DSI measurement is used for research purposes. It is 
measured on a mannequin leg during simulated gait at 
the frequency of 1 Hz (1 Hz = 1 gait cycle per second). DSI 
estimation in vivo is difficult, due to high variability of leg 
circumference changes at point B1 during walk. Therefore, 
static measurements including IP and SSI are preferred for 
daily practice rather than dynamic ones [10, 12, 13].
Clinical effects
Clinical effects of compression are shown in Table 4 
[34–37].
Contraindications to compression therapy
Despite obvious clinical benefits, not all patients are 
eligible for compression therapy. The list of contraindica-
tions to compression therapy has been getting ever short-
er. Some of once absolute contraindications have become 
relative contraindications (Table 5). An example is lower 
extremity artery disease (LEAD), with ABPI < 0.8, which 
is currently considered a relative contraindication to com-
pression therapy. Using compression therapy in such cases 
requires extensive experience. Another example is leg de-
formity. As it is now possible to manufacture compression 
products individually fitted to the size and shape of the ex-
tremity alongside using cushions and pads, leg deformity 
has become a relative contraindication. However, standard 
compression stockings cannot be used as it is impossible 
Table 4. Clinical benefits of compression therapy (CT) [2, 
7, 12, 15, 23–25, 27, 30, 31, 34–37]
Clinical benefits of compression therapy
Tissue effect 
• Endothelial cell activity stimulation: increased nitrous oxide 
production
• Inhibited lymphocyte adhesion
• Inhibited platelet aggregation
• Increased local and systemic fibrinolytic activity 
• Decreased production of inflammatory cytokines
• Local increase in oxygen partial pressure
• Reduced tissue iron overload
• Reduced skin hemosiderin deposits
• Decreased reactive oxygen species production
Increased tissue pressure, reduced pericapillary oedema
Improved microcirculation
Oedema reduction (CT range of 40–60 mm Hg)
Reduced venous volume and diameter
Accelerated venous flow, normalised arteriovenous gradient
Peripheral blood volume shift to the central compartment
Reduced venous reflux, intravenous pressure and stasis volume
Venous pump improvement/normalisation
Improved arterial inflow (IPC)
Improved lymph drainage
Decreased size and softening of lipodermatosclerosis
Accelerated venous leg ulcer (VLU) healing
Increased bone density
Subjective symptom improvement (pain, heaviness, itch and 
cramps) 
Better quality of life
Table 5. Contraindications to compression therapy (CT) [23, 24, 31]
Absolute Relative
1.  Severe heart failure concomitant with poorly controlled 
hypertension
1. Lower extremity artery disease with ABPI < 0.8
2. Previous vascular and/or skin grafting procedure 2.  Paper thin skin, prone to injury (especially over the bony prominences)
3. Severe all-cause peripheral neuropathy 3. Limb deformity
4. Acute skin and subcutaneous infections 4. Chronic skin and subcutaneous infections
5. Allergy to compression material
6. Lack of patient consent to treatment
7. Systolic pressure at the ankle level < 50 mm Hg*
8. Active phlebitis and deep vein thrombosis**
*Not true for IPC arterial systems. **Contraindication to intermittent pneumatic compression (IPC).
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to reliably determine the actual compression applied onto 
the deformed areas [23, 24].
Conclusions
A close link between chronic venous disease, civili-
sation-related factors and population aging results in 
increasing prevalence of CVD worldwide, whereas low 
public awareness of its chronic, progressive nature and 
complications delay prevention and treatment. CT is an 
established treatment method in chronic venous disease. 
Its key element involves educating the staff, the patients 
and their relatives in order to ensure their full involve-
ment and compliance. CT works by exerting external, an-
ti-gravity pressure on lower extremities, which improves 
the impaired venous outflow. Despite years of clinical 
experience, choosing optimum compression therapy, in-
cluding grade and pressure distribution, which determine 
the efficacy of treatment, still poses a challenge.
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